Parkinson disease (PD) is the most common neurodegenerative movement disorder. In
Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 …

Parkinson's disease is a common movement disorder seen in neurological practice, but the
diagnosis and management is challenging. The diagnosis is clinical and sometimes difficult …

Background and Objectives To review the current evidence on the options available for
initiating dopaminergic treatment of motor symptoms in early-stage Parkinson disease and …

Although levodopa remains the most efficacious symptomatic therapy for Parkinson disease
(PD), management of levodopa treatment during the advanced stages of the disease is …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of
dopaminergic neurons in the substantia nigra pars compacta (SNpc) resulting in dopamine …

Microneedle (MN) electrochemical sensors offer new strategies for personalized medicine
and point-to-point medical testing, providing new opportunities for disease diagnosis and …

Resting tremor in Parkinson's disease (PD) is one of the most distinctive motor symptoms.
Appropriate symptom monitoring can help to improve management and medical treatments …

Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and
are now widespread worldwide. Neuronal death is defined as the progressive loss of …

Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

A time span of 60 years covers the detection of catecholamines in the brain, their function in
movement and correlation to Parkinson's disease (PD). The clinical findings that orally given …